Not All PCPs Strongly Recommend HPV Vaccine

Share this content:
Not All PCPs Strongly Recommend HPV Vaccine
Not All PCPs Strongly Recommend HPV Vaccine

MONDAY, Jan. 4, 2016 (HealthDay News) -- Pediatricians and family physicians (FPs) do not always strongly recommend the human papillomavirus (HPV) vaccine, according to a study published online Jan. 4 in Pediatrics.

Mandy A. Allison, M.D., M.S.P.H., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues conducted a national survey among pediatricians (364 responders) and FPs (218 responders). The authors described self-reported practices regarding HPV vaccine recommendations, estimated the frequency of parental deferral of vaccination, and examined characteristics associated with not discussing vaccination.

The researchers found that 60 percent of pediatricians and 59 percent of FPs strongly recommended HPV vaccine for 11- to 12-year-old girls, while 52 and 41 percent, respectively, strongly recommended the vaccine for boys. More than half of the respondents reported that ≥25 percent of parents deferred vaccination. HPV vaccination was frequently/always discussed by 84 percent of pediatricians and 75 percent of FPs at the 11-12-year well visit. Those who occasionally/rarely discussed vaccination were more likely to be FPs, male, disagree that parents will accept the HPV vaccines if discussed with other vaccines, report that 25 to 49 or 50 or more percent of parents defer, and express concern about waning immunity, compared with those who frequently/always discussed vaccination.

"Addressing physicians' perceptions about parental acceptance of HPV vaccine, the possible advantages of discussing HPV vaccination with other recommended vaccines, and concerns about waning immunity could lead to increased vaccination rates," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »